02 Aug 2019
Microbiota

New prebiotics: benefits without the downsides?

Prebiotics are currently a preferred treatment for certain metabolic disorders, as they can restore the balance of dysfunctional gut microbiota, and improve the body’s metabolism. However, these substances have to be used at high doses, which can result in patients experiencing bloating and flatulence. A research group led by Matteo Serino, Inserm researcher at the Digestive Health Research Institute (Inserm/INRA/ENVT/UT3 Paul Sabatier), has recently shown three plant extracts to have prebiotic effects in obese/diabetic mice, with a shorter duration of treatment and at lower doses to the prebiotics currently in use. For Matteo Serino, this raises the question: do we need to reconsider the protocol for prebiotic administration? These results have been published in Molecular Nutrition & Food Research.

23 Jul 2019
19 Jul 2019
Metaprogrammes
  • Céréales et tournesols fleuris sur fond de ciel.. © INRA, BEGUEY Alain
  • Ciel d'orage en Eure et Loir.. © INRA, WEBER Jean
  • Biofilm mixte de Lactococcus lactis (coques jaunes) et de Listeria monocytogenes (bâtonnets roses), observé en microscopie électronique à balayage.. © inra, Thierry MEYLHEUC
  • Supermarché. © MAITRE Christophe
  • Floating market.. © INRA, Chloé Le Bastard